Scale opportunities Relevate Health serves 85 pharmaceutical manufacturers across 185 brands, including all 15 of the world’s largest global pharma companies, indicating wide potential for expanding strategic partnerships and cross-sell of their omnichannel activation platform.

Data‑driven advantage Powered by ELE Decision Engine with proprietary first‑party data and analytics, Relevate Health offers precision HCP engagement at critical moments, presenting a strong selling point for pharma teams seeking measurable Rx lift and guaranteed campaign outcomes.

Acquisition momentum Notable recent acquisitions of Level Ex pharma unit and Brainlab assets, plus leadership changes and office expansion, signal growth velocity and potential for cross‑selling consulting, digital therapeutics, and integrated gaming or simulation assets to pharma customers.

Tech stack fit Utilizing AWS, HIPAA compliance, Oracle, and modern web frameworks positions Relevate Health as a scalable, secure partner for large health systems and life sciences brands seeking compliant data‑driven marketing solutions.

Financial scale With estimated revenue in the hundreds of millions and substantial funding, Relevate Health has the financial heft to invest in product expansion, global expansion, and larger strategic deals with top pharma manufacturers.